close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Allan Lima Pereira

location-icon

Tampa, FL

LOCATION OF PRACTICE
Moffitt Cancer Center
MEDICAL Specialty:

Gastric Cancer



NPI Number
1144003989
ABOUT

Allan Lima Pereira, MD, PhD is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. Dr. Lima Pereira’s clinical interests are a spectrum of gastrointestinal cancers, including colorectal, pancreatic, gastric, esophageal and hepato-biliary cancers. His research interests are primarily in colorectal and hepatopancreatobiliary tumors, including biomarkers for better treatment selection and developing innovative clinical trials.

Dr. Allan Lima Pereira profile image

Published Articles

The rhizosphere microbiome as a decentralized immune system.- 2026 Mar 31
Association between puberty timing and metabolic health at Young adulthood.- 2026 Apr 1
Effectiveness of a myofunctional therapy program in the treatment of mouth breathing in patients with dental malocclusion: a pilot clinical trial.- 2026
Adaptation and validation into Spanish of the brief scale of mood regulation through music (B-MMR).- 2026 Mar 31
CGE26-142: Fluoropyrimidine-Associated Cardiotoxicity in DPYD Genetic Variants.- 2026 Mar 31
Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis.- 2026 Mar 28
Limited transferability of European-based body mass index and blood pressure polygenic scores to admixed Brazilian cohorts.- 2026
Association Between Metabolic and Endocrine Parameters With Visceral Adiposity Index-Defined Adipose Tissue Dysfunction in Young Adult Males.- 2026
Seroprevalence of Leishmania spp. Infection in Cats in Portugal.- 2026 Mar 15
Kombucha as a Bioactive Functional Beverage: Current Evidence, Production Challenges, and Future Perspectives.- 2026 Mar 17

Clinical Trials

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

My Patient Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider